Abbonarsi

Impact of a clinical atrial fibrillation risk estimation tool on cardiac rhythm monitor utilization following acute ischemic stroke: A prepost clinical trial - 08/03/25

Doi : 10.1016/j.ahj.2025.02.010 
Jeffrey M. Ashburner, PhD, MPH a, b, 1, , Reinier W.P. Tack, MD e, f, g, h, 1, Shaan Khurshid, MD, MPH c, d, e, Ashby C. Turner, MD f, Steven J. Atlas, MD, MPH a, b, Daniel E. Singer, MD a, b, Patrick T. Ellinor, MD, PhD c, d, Emelia J. Benjamin, MD, ScM i, j, Ludovic Trinquart, PhD k, l, Steven A. Lubitz, MD, MPH c, d, 2, Christopher D. Anderson, MD, MMSc e, g, h, m, 2
a Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA 
b Department of Medicine, Harvard Medical School, Boston, MA 
c Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA 
d Telemachus and Irene Demoulas Family Foundation Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston, MA 
e Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA 
f Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 
g McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 
h Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 
i Boston University and National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA 
j Sections of Cardiovascular Medicine, Department of Medicine, Boston Medical Center, Department of Epidemiology, Boston University Chobanian and Avedisian School of Medicine, Boston University School of Public Heath, Boston, MA 
k Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 
l Tufts Clinical and Translational Science Institute, Tufts University, Medford, MA 
m Department of Neurology, Brigham and Women's Hospital, Boston, MA 

Reprint requests: Jeffrey M. Ashburner, PhD, MPH, Division of General Internal Medicine, Massachusetts General Hospital, 100 Cambridge St, 16th Floor, Boston, MA 02114Division of General Internal MedicineMassachusetts General Hospital100 Cambridge St, 16th FloorBostonMA02114

Highlights

Clinician engagement with a best practice advisory alert that provided clinicians with clinically predicted risk of atrial fibrillation for stroke survivors was low.
Providing clinicians with clinically predicted 5-year risk of atrial fibrillation was not associated with the use of extended cardiac monitoring among stroke survivors.
The cumulative incidence of extended cardiac monitoring was higher in the intervention period compared to a preintervention period, but was not dependent on completion of the best practice advisory alert.

Il testo completo di questo articolo è disponibile in PDF.

Riassunto

Background

Detection of undiagnosed atrial fibrillation (AF) after ischemic stroke through extended cardiac monitoring is important for preventing recurrent stroke. We evaluated whether a tool that displays clinically predicted AF risk to clinicians caring for stroke patients was associated with the use of extended cardiac monitoring.

Methods

We prospectively included hospitalized ischemic stroke patients without known AF in a preintervention (October 2018 - June 2019) and intervention period (March 11, 2021 - March 10, 2022). The intervention consisted of an electronic health record (EHR)-based best-practice advisory (BPA) alert which calculated and displayed 5-year risk of AF. We used a multivariable Fine and Gray model to test for an interaction between predicted AF risk and period (preintervention vs intervention) with regards to incidence of extended cardiac monitoring. We compared the incidence of extended cardiac monitoring within 6-months of discharge between periods, stratified by BPA completion.

Results

We included 805 patients: 493 in the preintervention cohort and 312 in the intervention cohort. In the intervention cohort, the BPA was completed for 180 (58%) patients. The association between predicted clinical risk of AF and incidence of 6-month extended cardiac monitoring was not different by time period (interaction HR = 1.00 [95% Confidence Interval (CI) 0.98; 1.02]). The intervention period was associated with an increased cumulative incidence of cardiac monitoring (adjusted HR = 1.32 [95% CI 1.03-1.69]).

Conclusions

An embedded EHR tool displaying predicted AF risk in a poststroke setting had limited clinician engagement and predicted risk was not associated with the use of extended cardiac monitoring.

Clinical Trial Registration

NCT04637087

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Jeffrey M. Ashburner and Reinier W.P. Tack contributed equally to the present study and share first authorship.
 Steven A. Lubitz and Christopher D. Anderson contributed equally to the present study and share senior authorship.


© 2025  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 284

P. 57-66 - Giugno 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Pharmaco-invasive strategy and dosing of tenecteplase in STEMI patients 60 to <75 years: An inter-trial comparison of the STREAM-1 and STREAM-2 trials
  • Kevin R. Bainey, Robert C. Welsh, Yinggan Zheng, Alexandra Arias-Mendoza, Arsen D. Ristić, Oleg V. Averkov, Yves Lambert, Tracy Temple, Eric Ly, Kris Bogaerts, Peter Sinnaeve, Cynthia M. Westerhout, Frans Van de Werf, Paul W. Armstrong, STREAM-2 Investigators
| Articolo seguente Articolo seguente
  • Lipoprotein(a) immunoassays and their associations with coronary artery calcification and aortic valve calcification
  • Maarten J.G. Leening, Ching F. Khan, Fang Zhu, Sunny S. Singh, Maryam Kavousi, Eric J.G. Sijbrands, Yolanda B. de Rijke, Daniel Bos

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.